Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks

PLoS Genetics

Volumn 9, Issue 7, 2013, Pages

  Holdt, Lesca M ^a,b,c   Hoffmann, Steve ^a   Sass, Kristina ^b   Langenberger, David ^a   Scholz, Markus ^a   Krohn, Knut ^a,b   Finstermeier, Knut ^a,b   Stahringer, Anika ^b,c   Wilfert, Wolfgang ^b,c   Beutner, Frank ^a,b   Gielen, Stephan ^a   Schuler, Gerhard ^a   Gäbel, Gabor ^d   Bergert, Hendrik ^d   Bechmann, Ingo ^a   Stadler, Peter F ^a,e,f   Thiery, Joachim ^a,b   Teupser, Daniel ^a,b,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e MAX PLANCK INSTITUTE FOR MATHEMATICS IN THE SCIENCES   (Germany)

^f SANTA FE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE NONCODING RNA IN THE INK4 LOCUS; POLYCOMB GROUP PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ALU SEQUENCE; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME 9P; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EMBRYO; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENETIC RISK; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTAGENESIS; PROMOTER REGION; PROTEIN MOTIF;

ALU ELEMENTS; APOPTOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HUMANS; POLYCOMB-GROUP PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING;

EID: 84880799429     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003588     Document Type: Article

References (58)

1. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493.
2. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
3. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, et al. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
4. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genome-wide association analysis of coronary artery disease. New Engl J Med 357: 443-453.
5. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, et al. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 4: e7677.
6. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, et al. (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30: 620-627.
7. Holdt LM, Sass K, Gabel G, Bergert H, Thiery J, et al. (2011) Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 214: 264-270.
8. Holdt LM, Teupser D, (2012) Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 32: 196-206.
9. Fuster JJ, Molina-Sanchez P, Jovani D, Vinue A, Serrano M, et al. (2012) Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Atherosclerosis 221: 98-105.
10. Kim JB, Deluna A, Mungrue IN, Vu C, Pouldar D, et al. (2012) Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice. Circulation 126: 1896-1906.
11. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B, (2010) Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 6: e1000899.
12. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 29: 1671-1677.
13. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 4: e5027.
14. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, et al. (2007) RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316: 1484-1488.
15. Mattick JS, (2009) The genetic signatures of noncoding RNAs. PLoS Genet 5: e1000459.
16. Mercer TR, Dinger ME, Mattick JS, (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159.
17. Hung T, Chang HY, (2010) Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 7: 582-585.
18. Lee JT, (2012) Epigenetic regulation by long noncoding RNAs. Science 338: 1435-1439.
19. Wapinski O, Chang HY, (2011) Long noncoding RNAs and human disease (vol 21, pg 354, 2011). Trends in Cell Biology 21: 561-561.
20. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, et al. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30: 1956-1962.
21. Margueron R, Reinberg D, (2011) The Polycomb complex PRC2 and its mark in life. Nature 469: 343-349.
22. Lusis AJ, (2000) Atherosclerosis. Nature 407: 233-241.
23. Sato K, Nakagawa H, Tajima A, Yoshida K, Inoue I, (2010) ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 24: 701-707.
24. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106: 11667-11672.
25. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323.
26. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
27. Bracken AP, Helin K, (2009) Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9: 773-784.
28. Beutner F, Teupser D, Gielen S, Holdt LM, Scholz M, et al. (2011) Rationale and design of the Leipzig (LIFE) Heart Study: phenotyping and cardiovascular characteristics of patients with coronary artery disease. PLoS One 6: e29070.
29. Gonzalez I, Busturia A, (2009) High levels of dRYBP induce apoptosis in Drosophila imaginal cells through the activation of reaper and the requirement of trithorax, dredd and dFADD. Cell Res 19: 747-757.
30. Gregoire S, Karra R, Passer D, Deutsch MA, Krane M, et al. (2013) Essential and Unexpected Role of YY1 to Promote Mesodermal Cardiac Differentiation. Circ Res 112: 900-910.
31. Brookes E, de Santiago I, Hebenstreit D, Morris KJ, Carroll T, et al. (2012) Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell 10: 157-170.
32. Rudiger NS, Gregersen N, Kielland-Brandt MC, (1995) One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. Nucleic Acids Res 23: 256-260.
33. Deininger PL, Jolly DJ, Rubin CM, Friedmann T, Schmid CW, (1981) Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol 151: 17-33.
34. Weibrecht I, Gavrilovic M, Lindbom L, Landegren U, Wahlby C, et al. (2012) Visualising individual sequence-specific protein-DNA interactions in situ. N Biotechnol 29: 589-598.
35. Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, et al. (2012) CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 419: 612-616.
36. Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, et al. (2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220: 449-455.
37. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
38. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, et al. (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717-1720.
39. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT, (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-756.
40. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 5: e10693.
41. Simon JA, Kingston RE, (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
42. Morey L, Aloia L, Cozzuto L, Benitah SA, Di Croce L, (2013) RYBP and Cbx7 Define Specific Biological Functions of Polycomb Complexes in Mouse Embryonic Stem Cells. Cell Rep 3: 60-69.
43. Houseley J, Rubbi L, Grunstein M, Tollervey D, Vogelauer M, (2008) A ncRNA modulates histone modification and mRNA induction in the yeast GAL gene cluster. Mol Cell 32: 685-695.
44. Buske FA, Mattick JS, Bailey TL, (2011) Potential in vivo roles of nucleic acid triple-helices. RNA Biol 8: 427-439.
45. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY, (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44: 667-678.
46. Cowley M, Oakey RJ, (2013) Transposable Elements Re-Wire and Fine-Tune the Transcriptome. PLoS Genet 9 (1) (): e1003234.
47. Amaral PP, Mattick JS, (2008) Noncoding RNA in development. Mamm Genome 19: 454-492.
48. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464: 409-412.
49. Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, et al. (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19: 141-157.
50. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, et al. (2005) Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
51. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA, (2002) Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26: 182-190.
52. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
53. Schmid R, Baum P, Ittrich C, Fundel-Clemens K, Huber W, et al. (2010) Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3. BMC Genomics 11: 349.
54. Ihaka R, Gentleman R, (1996) R a language for data analysis and graphics. J Comp Graph Stat 5: 299-314.
55. Hoffmann S, Otto C, Kurtz S, Sharma CM, Khaitovich P, et al. (2009) Fast mapping of short sequences with mismatches, insertions and deletions using index structures. PLoS Comput Biol 5: e1000502.
56. Shin H, Liu T, Manrai AK, Liu XS, (2009) CEAS: cis-regulatory element annotation system. Bioinformatics 25: 2605-2606.
57. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. (2009) MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37: W202-208.
58. Tacker M, Fontana W, Stadler PF, Schuster P, (1994) Statistics of RNA melting kinetics. Eur Biophys J 23: 29-38.